ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
GLP-1 drugs like semaglutide linked to 15% lower fracture risk and greater weight loss in type 2 diabetes patients versus other obesity medications.
Read More
New Hampshire Senator Sue Prentiss introduced a bill to require Medicaid coverage for GLP-1 weight loss drugs for patients with BMI over 30.
Read More
A major U.S. hospital chain faced challenges covering GLP-1 weight loss drugs like Ozempic in employee health plans amid rising costs.
Read More
A VA study found type 2 diabetes patients stopping GLP-1 drugs regained weight and faced a 22% rise in cardiovascular risks.
Read More